Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
130.3 USD | +0.17% | +2.62% | +19.43% |
11:00am | BioMed X Announces the Start of A New Research Project in Partnership with Merck | CI |
04-29 | Merck Reports Positive Data for Investigational 21-Valent Pneumococcal Vaccine | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.43% | 330B | |
+35.40% | 664B | |
+29.35% | 567B | |
-7.22% | 354B | |
+4.56% | 286B | |
+13.43% | 234B | |
+5.22% | 199B | |
-9.98% | 196B | |
-4.71% | 148B | |
-10.47% | 145B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck & Co.'s COVID-19 Pill Granted Approval in Japan